These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8218611)

  • 21. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome (NMS) on neuroleptic withdrawal.
    Corrigan FM; Coulter F; Mackay AV
    Acta Psychiatr Scand; 1990 Sep; 82(3):268-9. PubMed ID: 1978961
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder.
    Joshi PT; Capozzoli JA; Coyle JT
    Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome secondary to loxapine.
    Chong LS; Abbott PM
    Br J Psychiatry; 1991 Oct; 159():572-3. PubMed ID: 1751872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroleptic malignant syndrome].
    Casas Fernández-Tejerina J; Pérez de Diego I; Estrada Castrillo P; Merino Angulo J
    Rev Clin Esp; 1987 Apr; 180(7):407-8. PubMed ID: 3602556
    [No Abstract]   [Full Text] [Related]  

  • 26. Atypical neuroleptic malignant syndrome associated with clozapine treatment.
    Amore M; Zazzeri N; Berardi D
    Neuropsychobiology; 1997; 35(4):197-9. PubMed ID: 9246221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic malignant syndrome.
    Paul GE; Landers DF; Newman T
    Nebr Med J; 1990 Mar; 75(3):46-9; discussion 49-50. PubMed ID: 2179748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.
    Pope HG; Keck PE; McElroy SL
    Am J Psychiatry; 1986 Oct; 143(10):1227-33. PubMed ID: 2876647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome in striatonigral degeneration.
    Gibb WR
    Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.
    Stotz M; Thümmler D; Schürch M; Renggli JC; Urwyler A; Pargger H
    Br J Anaesth; 2004 Dec; 93(6):868-71. PubMed ID: 15377584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuroleptic malignant syndrome: a review.
    Lazarus A
    Can J Psychiatry; 1986 Oct; 31(7):670-4. PubMed ID: 3536069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome: three episodes with different drugs.
    Lavie CJ; Ventura HO; Walker G
    South Med J; 1986 Dec; 79(12):1571-3. PubMed ID: 2878496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroleptic malignant syndrome].
    Lahoz CH; Guisasola L; Tuñón A; Solar M; Acebes A
    Rev Clin Esp; 1986 Oct; 179(6):334-5. PubMed ID: 3797740
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypothalamic pathology in the neuroleptic malignant syndrome.
    Horn E; Lach B; Lapierre Y; Hrdina P
    Am J Psychiatry; 1988 May; 145(5):617-20. PubMed ID: 2895986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperthermia with acute rhabdomyolysis in a psychotic treated with neuroleptics].
    Reis J; Felten P; Rumbach L; Collard M
    Rev Neurol (Paris); 1983; 139(10):595-6. PubMed ID: 6139869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome induced by nemonapride.
    Kubota T
    Acta Neurol (Napoli); 1993 Apr; 15(2):142-4. PubMed ID: 8328325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent spontaneous "neuroleptic malignant syndrome" in the absence of neuroleptic medication in probable dementia with Lewy bodies.
    Weber KE; Linker RA; Lorenz R; Muellges W; Naumann M; Reiners K; Classen J
    J Neurol; 2005 Sep; 252(9):1122-4. PubMed ID: 15765193
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.